Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kalra

Showing results (431-440 of 486) with videos related to

Pageof 49
Sort By:
BMC Nephrology|June 16, 2019
Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-studyDarren Green, Diana Vassallo, Kelly Handley, et al.
Clinical Kidney Journal|July 5, 2021
Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational studyMarc G Vervloet, Ioannis N Boletis, Angel L M de Francisco, et al.
JACC. Heart Failure|June 13, 2021
Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron TherapyPardeep S Jhund, Mark C Petrie, Michele Robertson, et al.
Journal of Cardiac Failure|November 5, 2023
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection FractionRobin Ray, Ian Ford, John G F Cleland, et al.
Cardiovascular Research|December 7, 2021
High-dose intravenous iron reduces myocardial infarction in patients on haemodialysisMark C Petrie, Pardeep S Jhund, Eugene Connolly, et al.
BMC Nephrology|January 16, 2014
The eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease--prospective longitudinal study in a multiethnic populationEdmund J Lamb, Elizabeth A Brettell, Paul Cockwell, et al.
Heart (British Cardiac Society)|August 10, 2022
Rationale and design of a randomised trial of intravenous iron in patients with heart failurePaul R Kalra, John Gf Cleland, Mark C Petrie, et al.
Journal of the American Society of Nephrology : JASN|June 20, 2025
Biomarkers of Kidney Failure and All-Cause Mortality in CKDAnthony Onoja, Thomas McDonnell, Isabelle Annessi, et al.
European Journal of Heart Failure|May 20, 2025
Recurrent event analyses in patients receiving maintenance dialysis and the effect of higher- versus lower-dose chronic intravenous iron therapy: A report focusing on heart failure events from the PIVOTAL trialStefan D Anker, Michele Robertson, John J V McMurray, et al.
Obesity Surgery|October 26, 2020
Improvements in Diabetic Neuropathy and Nephropathy After Bariatric Surgery: a Prospective Cohort StudySafwaan Adam, Shazli Azmi, Jan H Ho, et al.
Pageof 49

Showing results (431-440 of 486) with videos related to

Sort By:
Pageof 49
BMC Nephrology|June 16, 2019
Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-studyDarren Green, Diana Vassallo, Kelly Handley, et al.
Clinical Kidney Journal|July 5, 2021
Real-world safety and effectiveness of sucroferric oxyhydroxide for treatment of hyperphosphataemia in dialysis patients: a prospective observational studyMarc G Vervloet, Ioannis N Boletis, Angel L M de Francisco, et al.
JACC. Heart Failure|June 13, 2021
Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron TherapyPardeep S Jhund, Mark C Petrie, Michele Robertson, et al.
Journal of Cardiac Failure|November 5, 2023
The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection FractionRobin Ray, Ian Ford, John G F Cleland, et al.
Cardiovascular Research|December 7, 2021
High-dose intravenous iron reduces myocardial infarction in patients on haemodialysisMark C Petrie, Pardeep S Jhund, Eugene Connolly, et al.
BMC Nephrology|January 16, 2014
The eGFR-C study: accuracy of glomerular filtration rate (GFR) estimation using creatinine and cystatin C and albuminuria for monitoring disease progression in patients with stage 3 chronic kidney disease--prospective longitudinal study in a multiethnic populationEdmund J Lamb, Elizabeth A Brettell, Paul Cockwell, et al.
Heart (British Cardiac Society)|August 10, 2022
Rationale and design of a randomised trial of intravenous iron in patients with heart failurePaul R Kalra, John Gf Cleland, Mark C Petrie, et al.
Journal of the American Society of Nephrology : JASN|June 20, 2025
Biomarkers of Kidney Failure and All-Cause Mortality in CKDAnthony Onoja, Thomas McDonnell, Isabelle Annessi, et al.
European Journal of Heart Failure|May 20, 2025
Recurrent event analyses in patients receiving maintenance dialysis and the effect of higher- versus lower-dose chronic intravenous iron therapy: A report focusing on heart failure events from the PIVOTAL trialStefan D Anker, Michele Robertson, John J V McMurray, et al.
Obesity Surgery|October 26, 2020
Improvements in Diabetic Neuropathy and Nephropathy After Bariatric Surgery: a Prospective Cohort StudySafwaan Adam, Shazli Azmi, Jan H Ho, et al.
Pageof 49